Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma
Clinical trial NCT04782765 · UNKNOWN
Trial details
- NCT number
- NCT04782765
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-20
- Primary completion
- 2023-03-20
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.